Insider Trading March 19, 2026

Cisco Executive Sells $249,745 in Stock as Company Posts Fiscal Q2 Beat; Analysts Split on Outlook

Oliver Tuszik executed a Rule 10b5-1 sale on March 18, 2026, while Cisco reports stronger-than-expected results amid mixed analyst reactions

By Avery Klein CSCO
Cisco Executive Sells $249,745 in Stock as Company Posts Fiscal Q2 Beat; Analysts Split on Outlook
CSCO

Oliver Tuszik, Cisco's executive vice president for global sales, sold 3,132 shares on March 18, 2026, under a Rule 10b5-1 plan adopted December 17, 2025, for $249,745. After the trade Tuszik directly holds 188,612.992 shares, which includes 1,221.059 dividend equivalents on unvested restricted stock units. The transaction arrives as Cisco reported fiscal second-quarter 2026 adjusted EPS of $1.04 on $15.3 billion in revenue, topping analyst forecasts. Analysts reacted with divergent views on valuation and margins.

Key Points

  • Oliver Tuszik sold 3,132 Cisco shares on March 18, 2026, for a total of $249,745 under a Rule 10b5-1 plan.
  • Cisco beat fiscal Q2 2026 forecasts with adjusted EPS of $1.04 and revenue of $15.3 billion.
  • Analysts reacted differently: UBS raised its price target to $95 (Buy), Erste Group downgraded to Hold citing gross margin concerns, and BofA reiterated Buy at $95 while noting enterprise-agreement trends that support security product adoption.

Transaction details

Oliver Tuszik, executive vice president for global sales at Cisco Systems, sold 3,132 shares of company stock on March 18, 2026, at a per-share price of $79.74, yielding a total transaction value of $249,745. The disposition was made under a Rule 10b5-1 trading plan that Tuszik adopted on December 17, 2025.

Following the sale, Tuszik's direct holdings in Cisco amount to 188,612.992 shares. That total includes 1,221.059 dividend equivalents accrued on unvested restricted stock units.


Company results and analyst reactions

Cisco reported fiscal second-quarter 2026 adjusted earnings per share of $1.04, ahead of a $1.02 analyst forecast, and revenue of $15.3 billion, compared with expectations of $15.11 billion. The company’s results have prompted a range of responses from sell-side firms.

UBS raised its price target on Cisco to $95 from $90 and kept a Buy rating, citing strong performance in key metrics, including AI and product orders. By contrast, Erste Group downgraded the stock to Hold from Buy, pointing to concerns about the company’s gross margin outlook despite forecasting roughly $61.5 billion in sales for fiscal 2026. BofA Securities maintained its Buy recommendation with a $95 price target, noting strengths in AI and cloud and highlighting a customer shift toward enterprise-agreement buying programs that consolidate software and services into unified contracts - a trend the firm said is supporting adoption of Cisco’s security products.


Context and considerations

The insider sale was processed under a pre-existing Rule 10b5-1 plan, and Tuszik retains a substantial direct equity stake in the company following the transaction. At the same time, Cisco’s quarter beat on both adjusted EPS and revenue versus the cited analyst expectations, and broker-dealer reactions have been mixed, reflecting differing assessments of margin trends and the company’s sales mix.

Key takeaway

The combination of an executive stock sale, an earnings beat, and divergent analyst commentary underscores a period of active investor scrutiny for Cisco as it reports results and adjusts to evolving customer procurement patterns.

Risks

  • Erste Group flagged concerns about Cisco’s gross margin outlook, creating uncertainty for hardware and networking sectors that depend on margin stability.
  • Divergent analyst views - with upgrades and downgrades from UBS, Erste Group, and reiteration from BofA - may contribute to investor uncertainty in the networking and enterprise software segments.

More from Insider Trading

Alignment Healthcare CHRO Disposes $425k in Shares Across Two Transactions Mar 19, 2026 CytomX SVP Sells Shares to Cover RSU Taxes as Company Advances Clinical and Financing Plans Mar 19, 2026 Silver Lake Sells $36.7M in Dell Shares as Company Reports Strong AI Server Performance Mar 19, 2026 CytomX CFO Sells $124,111 in Stock as Company Advances Clinical Programs and Launches Large Offering Mar 19, 2026 Silver Lake Entities Liquidate $36.6M in Dell Class C Stock Amid Ongoing AI Momentum Mar 19, 2026